Health & Beauty

According to the observation report of Huacheng import and export data, recently, the demand for household regular medicines for epidemic prevention and protection has surged. According to the data of Baidu search index, recently, the search index for keywords such as "fever", "cough and expectoration", "ibuprofen", "Lianhua Qingwen" and "Pudilla" has entered a stage of rapid improvement, and the production capacity of drug source manufacturers has also attracted much attention.

How about the production of anti epidemic and protective drugs, and whether the market supply can be guaranteed?

On the morning of December 21, in the workshop of Lianhua Qingwen Granules of Yiling Pharmaceutical, more than ten automatic production lines were running at high speed, and boxes of Lianhua Qingwen Granules were scanned and packed in a busy scene

Even the staff of Huaqingwen Capsule Workshop are busy. Whether the batch number is printed completely, whether the aluminum plastic plate has burrs, and whether the embossing of the aluminum plastic plate is clear... The inspection personnel and the sampling personnel strictly check to ensure the drug quality.

"We have built a quality management system with a full life cycle of 'all varieties, all directions, all processes, all coverage, and all personnel', and created a quality system model of interlocking and closed-loop management." Wang Gang, the quality director of Yiling Pharmaceutical, said that since the rush to produce, all the quality departments have been on duty to strictly control the "seven passes" of drugs, so as to ensure the quality of each batch of products and drug safety, Huacheng Import and Export Data Observation Report.

Zhang Yunling, Executive Deputy General Manager of Yiling Pharmaceutical, introduced: "With the continuous improvement of market demand, we quickly responded and took various measures to adjust the production line in a timely manner in accordance with the management principle of 'tight and orderly, busy but not disorderly, check at all levels, ensure quality and safety in production', so as to put full power into the rush of production of Lianhua Qingwen. At present, Shijiazhuang, Hengshui and Beijing three production bases are all used for production under the condition that they meet the normal operation of other drugs of the company The production of Lianhua Qingwen series products has greatly improved the production capacity and fully met the market demand with quality and quantity guaranteed. And recently, the supply price of Lianhua Qingwen Capsules (granules) has remained stable. "

In the face of the situation that "Lianhua Qingwen is in short supply" in the market, Zhang Yunling also explained: "The temporary shortage of goods in some regions is related to many factors, such as whether the local logistics is unblocked and whether the goods in the pharmacy are put on the shelves in time. As a manufacturer, we will always try our best to ensure the supply of drugs according to the market demand now and in the future, and try our best to meet the health needs of the general public."

In addition to Lianhua Qingwen production enterprises increasing horsepower to ensure supply, ibuprofen and acetaminophen preparation enterprises are also gradually releasing capacity.

According to the observation report of Huacheng import and export data, Xinhua Pharmaceutical said on the interactive platform on December 21 that the company is actively cooperating with the relevant requirements of the national epidemic prevention policy, working overtime to produce drugs urgently needed in the market, and making every effort to ensure market supply.

According to the announcement of Northeast Pharmaceutical on December 20, the market demand for antipyretic and analgesic drugs has increased recently. Adhering to the mission of "China Pharmaceutical", the company has stepped up the production of paracetamol tablets, compound paracetamol and amantadine tablets and vitamin C series preparations according to market demand to fully ensure market supply.

On December 19, Teyi Pharmaceutical said on the investor interaction platform that, according to the Medication Catalogue for COVID-19 Infected Persons (First Edition), the company's acetaminophen tablets, ibuprofen tablets and diclofenac sodium enteric coated tablets are suitable for fever symptoms, and compound paracetamol and amantadine capsules are suitable for fever, runny nose, stuffy nose, sneezing and other cold symptoms. At present, the sales of the above products are good, and the company has produced at full capacity to ensure market demand.

The supply of raw materials is guaranteed

Facing the rapidly growing market demand, will there be a shortage of raw materials for the production of Lianhua Qingwen? Zhang Yunling said: "The company has a strategic inventory of its main raw materials, which can cope with the surge in consumption."

"Traditional Chinese medicine has a certain attribute of agricultural products, and is affected by weather, natural environment, growth cycle, market supply and demand and other factors. The company has established a safety stock early warning system for strategic varieties to monitor the reserve of traditional Chinese medicine in real time and ensure the normal production of products. In addition, the company has many self built and co built raw material planting and processing bases, as well as core suppliers, which can ensure the normal supply of other auxiliary materials and packaging The production capacity of material suppliers has increased rapidly, and the supply can be guaranteed. " Zhang Yunling further said.

"Take Forsythia suspensa as an example, it is one of the main components of Lianhua Qingwen. In recent years, the company has vigorously promoted the development of Forsythia suspensa in the Taihang Mountain industrial belt, vigorously promoted the breeding and breeding of fine varieties, standardized planting management, standardized processing, comprehensive utilization and other aspects, and established three major bases in Shexian County, Wu'an City, Handan City, and Jingxing County, Shijiazhuang City, with a planting area of more than 100000 mu." Zhang Yunling said that in addition to Forsythia suspensa, There are planting bases for raw medicinal materials such as honeysuckle and isatis root needed for the production of Lianhua Qingwen, which will continuously meet the production demand of Lianhua Qingwen with quality and quantity guaranteed.

In addition to the guaranteed supply of traditional Chinese medicine, the production capacity of ibuprofen and other APIs can also meet the demand.

According to the Huacheng Import and Export Data Observation Report, according to the data of the State Food and Drug Administration, there are 194 kinds of antipyretic, cough relieving, antibacterial and antiviral drugs that have been listed in China, involving more than 9000 approval documents. According to the survey of some enterprises, the production capacity of ibuprofen and acetaminophen in China is relatively sufficient, which can meet the production demand of domestic preparations.

Since October, the sales volume of Kangzhi Pharmaceutical's ibuprofen granules, nimesulide granules, aminophenol Huangmin granules, levocetirizine granules, Ganmao Qingre granules, cough relieving orange red granules and other products has soared. Kangzhi Pharmaceutical also said in the investor survey that the company guarantees smooth production. The company's production base adopts such methods as coordinating internal resources, adjusting production scheduling, implementing multi shift system, expanding production lines and actively seeking external support to rapidly increase production capacity, which can basically gradually ensure market supply. In terms of raw material reserves, the company coordinated with the upstream to ensure supply, and allocated equipment from the group to Hainan base. The original equipment in Hainan base was operated in multiple shifts, Huacheng Import and Export Data Observation reported.